Blood, Injection, Injury Type Phobia Clinical Trial
Official title:
Endoscopic Injection of Autologous Blood Versus Diluted Epinephrine for Control of Actively Bleeding Gastroduodenal Ulcers
Verified date | September 2013 |
Source | Zagazig University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Egypt: Zagazig University |
Study type | Interventional |
Endoscopic injection of autologous blood can control bleeding from gastroduodenal ulcers.
Status | Completed |
Enrollment | 100 |
Est. completion date | September 2013 |
Est. primary completion date | September 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 16 Years to 60 Years |
Eligibility |
Inclusion Criteria: - all adult patients with gastroduodenal ulcer Exclusion Criteria: - Patients with non ulcer bleeding. - Patients with malignancy. - Patients with bleeding disorders or under coagulation therapy. - Patients with known allergy to epinephrine. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Egypt | Zagazig University Hospitals | Zagazig | Sharkia |
Lead Sponsor | Collaborator |
---|---|
Zagazig University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | hemostasis from the ulcer after injection and/or stoppage of haematemesis and melena one day after the procedure. | 12 months | Yes | |
Secondary | development of re-bleeding after 24 hours after the procedure (occurrence of hematemesis or melena or drop of hemoglobin level >2gm/dl). | 12 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06336031 -
Impact of Blood Phobia on Fainting Susceptibility
|
N/A |